rhein has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Lin, D; Lin, J; Lin, Z; Wang, P; Xu, J; Zhang, D; Zhou, C | 1 |
| Bian, L; Duan, X; Feng, Y; Gao, M; Huang, D; Ji, A; Jin, Q; Luo, Q; Ni, Y; Su, C; Yin, Z; Zhang, D; Zhang, J | 1 |
2 other study(ies) available for rhein and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Tetramethylpyrazine-Rhein Derivative inhibits the migration of canine inflammatory mammary carcinoma cells by mitochondrial damage-mediated apoptosis and cadherins downregulation.
Topics: Animals; Apoptosis; Cadherins; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dogs; Down-Regulation; Lung Neoplasms | 2023 |
Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis.
Topics: Animals; Anthraquinones; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Contrast Media; Copper Radioisotopes; DNA; Heterocyclic Compounds; Humans; Infarction; Intercalating Agents; Liver; Magnetic Resonance Imaging; Male; Muscles; Necrosis; Organometallic Compounds; Rats, Sprague-Dawley; Reperfusion Injury | 2018 |